Rua Bioscience Limited (NZE:RUA)

Rua Bioscience Revenue

In the fiscal year ending June 30, 2026, Rua Bioscience had annual revenue of 2.81M NZD with 53.88% growth. Rua Bioscience had revenue of 1.36M in the half year ending June 30, 2026, with 674.76% growth. That makes Rua Bioscience the 42,799th largest company in the world by revenue and 97th in New Zealand.

• Revenue: 2.81M
• Revenue Growth: +53.88%
• P/S Ratio: 3.14
• Revenue / Employee: n/a
• Employees: 30
• Market Cap: 8.83M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• New Zealand 1.30M 50.2%
• Australia 1.03M 39.7%
• Europe 260.55K 10.1%

Fiscal year ended Jun 30, 2026 See the full Rua Bioscience breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	2.81M	984.14K	53.88%
Jun 30, 2025	1.83M	1.51M	477.39%
Jun 30, 2024	316.35K	-352.13K	-52.68%
Jun 30, 2023	668.48K	23.39K	3.63%
Jun 30, 2022	645.10K	285.76K	79.52%

Data Source: S&P Global Market Intelligence Last updated: Sep 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 19, 2026

Data Sources Report a data error